Knowledge Questionnaire on Viral Hepatitis for Drug Service Staff

Summary: 

This knowledge questionnaire has been developed by the EMCDDA as part of its initiative to increase access to hepatitis C care through drug services. The main aims of the knowledge questionnaire are:

  • to refresh knowledge on hepatitis C virus (HCV) and hepatitis B virus (HBV) transmission, testing and care for people who inject drugs (PWID) among those working in drug treatment settings;
  • to increase awareness of staff of the importance of knowing their own status;
  • to provide a tool for managers of drug treatment facilities, or other actors, who would like to identify the training needs of staff.

The knowledge questionnaire covers a wide range of aspects regarding HCV and HBV such as prevalence, routes of transmission, prevention measures, treatment and testing options, and international recommendations on testing and treatment. It consists of a series of true statements which provide factual information on viral hepatitis and it can be administered as an online survey or on paper. The answer format ‘I knew it already’ or ‘This is new to me’ allows participants to assess their own level of knowledge and refresh it, which facilitates an honest self-assessment, avoiding a test situation with true or false statements, that may feel threatening.

Your Guide to Integrating HCV Services into Opioid Treatment Programs - ATTC Network

The opioid epidemic has resulted in significant increases in Hepatitis C Virus (HCV) among people who inject drugs, accounting for 23% of new infections. HCV is completely curable and testing and treatment are the path to cure. Opioid Treatment Providers (OTPs) play a critical role in comprehensive approaches to addressing HCV and this guide is one tool to help.

Your Guide to Integrating HCV Services into Opioid Treatment Programs can help build the capacity of publicly funded OTPs to integrate HCV prevention and treatment services into their programs. This guide may also be useful for Federally Qualified Health Centers (FQHCs), community and healthcare coalitions, nonprofit organizations and other substance use disorder and HCV treatment providers. 
 

ATTC HCV guide cover
Jose Luis Vazquez Martinez

Part of the Integrated Care Series, Dr. Deepa Rao presents socio-behavioral and mental health-related barriers to engagement in care for people with HIV.

9th International Conference on Hepatitis Care in Substance Users

Event Date
City/Region/State
Glasgow
Country
United Kingdom

The 9th International Conference on Hepatitis Care in Substance Users will be held in Glasgow, Scotland, 8 – 10 October 2020.

The INHSU annual conference is a unique opportunity to connect with the global community working to improve health outcomes for people who use drugs including the prevention, treatment and care of hepatitis C.

Join with researchers, policy makers, advocates, practitioners and people who use drugs to share knowledge, learn from each other and amplify the evidence.

The conference is hosted by the International Network on Hepatitis in Substance Users (INHSU).

Key Deadlines

Abstract Submission15 March, 2020

Scholarship Applications: 15 March, 2020

Jose Luis Vazquez Martinez

In this presentation, Dr. Valerie Earnshaw provides a cross-cutting conceptual overview of stigma, identifies targets for stigma measurement, recommends methodological approaches for stigma research, and reviews the intervention toolkit to address stigma.

National Conference: Hepatitis C Case-finding in Addiction Related Services

Event Date
City/Region/State
Stirling
Country
United Kingdom

This FREE one day conference, organised by Hepatitis Scotland, is aimed at staff who work in, or have strategic responsibility for, primary and secondary care addiction services.

The day will explore the background to developing successful hepatitis C case-finding initiatives, demonstrating real world successes and issues for practitioners to consider.

There will also be an opportunity to contribute to guidelines for opt out BBV testing in addiction services.

Jose Luis Vazquez Martinez

Source: Bórquez, A., Abramovitz, D., Cepeda, J., Rangel, G., González-Zúñiga, P., Martin, N., Magis-Rodríguez, C., & Strathdee, S. (2019). Syringe sharing among people who inject drugs in Tijuana: before and after the Global Fund. Salud Mental, 42(4), 149-156.

Jose Luis Vazquez Martinez

The authors concluded: "In sum, this drug user population in Guatemala City is at heightened risk of HIV, although some of the risk results from overlap with vulnerability experienced as members of groups at heightened risk, such as gay/bisexual men, transgender women, and sex workers.